MRSN - Mersana Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts5556
Avg. Estimate-0.37-0.39-0.61-1.41
Low Estimate-0.39-0.42-0.78-1.84
High Estimate-0.36-0.36-0.38-1.2
Year Ago EPS-0.75-0.97-2.79-0.61
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts5556
Avg. Estimate350k350k41.93M2.67M
Low EstimateN/AN/A41.24MN/A
High Estimate1M1M43.2M6M
Year Ago Sales2.15M1.19M10.59M41.93M
Sales Growth (year/est)-83.70%-70.50%295.80%-93.60%
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.-0.59-0.69-0.02-0.38
EPS Actual-0.75-0.970.7-0.36
Difference-0.16-0.280.720.02
Surprise %-27.10%-40.60%3,600.00%5.30%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.37-0.39-0.61-1.41
7 Days Ago-0.37-0.39-0.61-1.41
30 Days Ago-0.4-0.42-0.71-1.5
60 Days Ago-0.4-0.42-0.71-1.5
90 Days Ago-0.4-0.42-0.71-1.5
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days4443
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesMRSNIndustrySectorS&P 500
Current Qtr.50.70%N/AN/A-0.00
Next Qtr.59.80%N/AN/A0.08
Current Year78.10%N/AN/A0.03
Next Year-131.10%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A